20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PREGABALIN, with a corresponding US DMF Number 26246.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2015, and payment made on May 20, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II